Published in Emerg Infect Dis on February 04, 1997
mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother (1997) 4.38
Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother (1997) 3.27
Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob Agents Chemother (1999) 2.52
Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California. J Clin Microbiol (1999) 1.59
Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol (2007) 1.48
Epidemiologic analysis of invasive and noninvasive group a streptococcal isolates in Hong Kong. J Clin Microbiol (2003) 1.34
Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur J Clin Microbiol Infect Dis (1998) 1.30
Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. Emerg Infect Dis (1999) 1.29
Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania. Antimicrob Agents Chemother (2004) 1.06
Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. Antimicrob Agents Chemother (2002) 1.04
Erythromycin resistance in Streptococcus pyogenes in Italy. Emerg Infect Dis (2000) 0.94
Erythromycin-resistant group a streptococcal isolates collected between 2000 and 2005 in Oahu, Hawaii, and their emm types. J Clin Microbiol (2005) 0.86
Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data. Antimicrob Agents Chemother (2003) 0.85
In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States. Antimicrob Agents Chemother (2005) 0.83
Susceptibility of group A beta-hemolytic streptococci in the lower St Lawrence region, Quebec. Can J Infect Dis (1999) 0.80
Identification of B- and T-cell epitopes within the fibronectin-binding domain of the SfbI protein of Streptococcus pyogenes. Infect Immun (2003) 0.78
Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother (1995) 9.40
Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother (1996) 8.65
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother (1991) 7.18
Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother (1993) 4.83
Resistance to erythromycin in group A streptococci. N Engl J Med (1992) 4.42
Chimeric streptococcal plasmids and their use as molecular cloning vehicles in Streptococcus sanguis (Challis). J Bacteriol (1980) 3.34
Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis (1996) 2.51
Detection of erythromycin resistance by the polymerase chain reaction using primers in conserved regions of erm rRNA methylase genes. Antimicrob Agents Chemother (1990) 2.49
Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses. J Antimicrob Chemother (1987) 2.06
Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis (1990) 1.91
Evolution and epidemiology of MLS resistance. J Antimicrob Chemother (1985) 1.81
The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Med J Aust (1989) 1.79
Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis (1991) 1.75
Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan. Am J Dis Child (1979) 1.71
Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother (1995) 1.61
The resurgence of group A streptococcal infections and their sequelae. Eur J Clin Microbiol Infect Dis (1991) 1.51
Erythromycin-resistant Streptococcus pyogenes. J Antimicrob Chemother (1990) 1.49
Trends in bacteremic infection due to Streptococcus pyogenes (group A streptococcus), 1986-1995. Emerg Infect Dis (1996) 0.96
Susceptibility of macrolide and beta-lactam antibiotics of Streptococcus pyogenes strains isolated over a four-year period in central Italy. J Chemother (1996) 0.81
Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother (1999) 9.01
Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst (2000) 6.77
Appearance of IMP-1 metallo-beta-lactamase in Europe. Lancet (1999) 5.41
Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla(IMP) allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother (2000) 5.26
Identification of a streptococcal penicillin-binding protein that reacts very slowly with penicillin. J Bacteriol (1983) 4.42
Regulation of penicillin-binding protein activity: description of a methicillin-inducible penicillin-binding protein in Staphylococcus aureus. Antimicrob Agents Chemother (1985) 3.98
The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care (2001) 3.67
Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol (2001) 2.83
Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase. Clin Infect Dis (2000) 2.61
Genotypic identification of methicillin-resistant coagulase-negative staphylococci by polymerase chain reaction. Antimicrob Agents Chemother (1991) 2.61
rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy. J Clin Microbiol (1999) 2.32
In70 of plasmid pAX22, a bla(VIM-1)-containing integron carrying a new aminoglycoside phosphotransferase gene cassette. Antimicrob Agents Chemother (2001) 2.29
Transition from resistance to hypersusceptibility to beta-lactam antibiotics associated with loss of a low-affinity penicillin-binding protein in a Streptococcus faecium mutant highly resistant to penicillin. Antimicrob Agents Chemother (1985) 2.19
Solubilization and isolation of the membrane-bound DD-carboxypeptidase of Streptococcus faecalis ATCC9790. Properties of the purified enzyme. Eur J Biochem (1978) 2.10
Comparison of the MB/BacT and BACTEC 460 TB systems for recovery of mycobacteria from various clinical specimens. J Clin Microbiol (1999) 2.09
The penicillin-binding proteins in Streptococcus faecalis ATCC 9790. Eur J Biochem (1980) 2.07
Identification of the lethal target of benzylpenicillin in Streptococcus faecalis by in vivo penicillin binding studies. Nature (1980) 1.96
Identification of 54 mycobacterial species by PCR-restriction fragment length polymorphism analysis of the hsp65 gene. J Clin Microbiol (2001) 1.95
Bacteriolytic activity in staphylococci. Infect Immun (1977) 1.90
Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitum beta-lactamase genes cloned from a natural isolate and a high-level beta-lactamase producer. Mol Microbiol (1994) 1.86
Molecular heterogeneity of bla(VIM-2)-containing integrons from Pseudomonas aeruginosa plasmids encoding the VIM-2 metallo-beta-lactamase. FEMS Microbiol Lett (2001) 1.80
Penicillin-binding proteins and the intrinsic resistance to beta-lactams in gram-positive cocci. J Antimicrob Chemother (1985) 1.73
Carbapenem-resistant Pseudomonas aeruginosa with acquired bla(vim) metallo-beta-lactamase determinants, Italy. Emerg Infect Dis (2000) 1.65
Reliability of the MB/BacT system for testing susceptibility of Mycobacterium tuberculosis complex isolates to antituberculous drugs. J Clin Microbiol (2000) 1.62
Streptococcus faecium ATCC 9790 penicillin-binding proteins and penicillin sensitivity are heavily influenced by growth conditions: proposal for an indirect mechanism of growth inhibition by beta-lactams. J Bacteriol (1983) 1.60
Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control. Diabet Med (2005) 1.59
Overproduction of a low-affinity penicillin-binding protein and high-level ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother (1994) 1.59
Gastroesophageal reflux and bronchial asthma: prevalence and effect of cisapride therapy. J Pediatr Gastroenterol Nutr (1993) 1.55
Diffusion of meropenem and imipenem through the outer membrane of Escherichia coli K-12 and correlation with their antibacterial activities. Antimicrob Agents Chemother (1992) 1.54
In Streptococcus faecium penicillin-binding protein 5 alone is sufficient for growth at sub-maximal but not at maximal rate. J Gen Microbiol (1986) 1.51
Enterococcus spp. produces slime and survives in rat peritoneal macrophages. Med Microbiol Immunol (2001) 1.47
Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. Ital J Gastroenterol Hepatol (1999) 1.42
Peptidoglycan synthesis in cocci and rods of a pH-dependent, morphologically conditional mutant of Klebsiella pneumoniae. J Bacteriol (1979) 1.40
Changes in autonomic nervous function over a 5-year period in non-insulin-dependent diabetic patients. Diabet Med (1993) 1.39
Nonradioactive DNA probe for detection of gene for methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1991) 1.39
Identification of a gene (arpU) controlling muramidase-2 export in Enterococcus hirae. J Bacteriol (1995) 1.38
Streptococcus faecium mutants that are temperature sensitive for cell growth and show alterations in penicillin-binding proteins. J Bacteriol (1987) 1.38
Identification of a genetic element (psr) which negatively controls expression of Enterococcus hirae penicillin-binding protein 5. J Bacteriol (1993) 1.36
Group B streptococci persist inside macrophages. Immunology (1998) 1.36
Characterization of a beta-lactamase produced in Mycobacterium fortuitum D316. Biochem J (1990) 1.35
Randomized trial of 2 versus 5 years of adjuvant tamoxifen for women aged 50 years or older with early breast cancer: Italian Interdisciplinary Group Cancer Evaluation Study of Adjuvant Treatment in Breast Cancer 01. J Clin Oncol (2003) 1.33
Relative importances of outer membrane permeability and group 1 beta-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae. Antimicrob Agents Chemother (1995) 1.29
Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60. Antimicrob Agents Chemother (1998) 1.29
Use of the chromosomal class A beta-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory beta-lactam compounds. Antimicrob Agents Chemother (1994) 1.29
Bacteriostatic and bactericidal activities of beta-lactams against Streptococcus (Enterococcus) faecium are associated with saturation of different penicillin-binding proteins. Antimicrob Agents Chemother (1987) 1.26
Detection of bacterial phosphatase activity by means of an original and simple test. J Clin Pathol (1979) 1.26
Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis. Infect Immun (1990) 1.25
Adherence of group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid. Infect Immun (1987) 1.24
Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance. Clin Infect Dis (1998) 1.23
Comparative evaluation of ligation-mediated PCR and spoligotyping as screening methods for genotyping of Mycobacterium tuberculosis strains. J Clin Microbiol (1999) 1.23
Control of cell septation by lateral wall extension in a pH-conditional morphology mutant of Klebsiella pneumoniae. J Bacteriol (1980) 1.22
Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project. Eur J Clin Microbiol Infect Dis (2012) 1.22
Modification of penicillin-binding protein 5 associated with high-level ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother (1996) 1.21
Intrinsic penicillin resistance in enterococci. Microb Drug Resist (1996) 1.20
Characterization of a conditional mutant with altered envelope showing pH-dependent morphology and temperature-dependent division. J Gen Microbiol (1974) 1.19
Different staphylococcal species contain various numbers of penicillin-binding proteins ranging from four (Staphylococcus aureus) to only one (Staphylococcus hyicus). J Bacteriol (1985) 1.19
Hematin-catalyzed epoxidation of 7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by polyunsaturated fatty acid hydroperoxides. J Biol Chem (1985) 1.18
The relationship between physicians' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes. The QuED Study Group--quality of care and outcomes in type 2 diabetes. Diabetes Care (2001) 1.17
Brief report: no evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure. Dig Dis Sci (2006) 1.16
Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci. Infect Immun (1994) 1.16
Overweight and hypertension : a 2-way street? Hypertension (2000) 1.15
Redox modulation of cell surface protein thiols in U937 lymphoma cells: the role of gamma-glutamyl transpeptidase-dependent H2O2 production and S-thiolation. Free Radic Biol Med (1999) 1.15
Electrotransformation of Streptococcus agalactiae with plasmid DNA. FEMS Microbiol Lett (1994) 1.14
Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status. Am J Gastroenterol (1998) 1.14
Accelerated bone mass senescence after hematopoietic stem cell transplantation. Transl Med UniSa (2013) 1.13
Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci). Infect Immun (1993) 1.12
Division blocks in temperature-sensitive mutants of Streptococcus faecium (S. faecalis ATCC 9790). J Bacteriol (1983) 1.10
Alterations in peptidoglycan chemical composition associated with rod-to-sphere transition in a conditional mutant of Klebsiella pneumoniae. J Bacteriol (1979) 1.09
Helicobacter pylori, pre-neoplastic changes, gastric cancer: a point of view. Eur J Gastroenterol Hepatol (1999) 1.08
Vancomycin-resistant Bacillus circulans carrying the vanA gene responsible for vancomycin resistance in enterococci. Eur J Clin Microbiol Infect Dis (1997) 1.08
Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis. Microb Drug Resist (1999) 1.08
The two-competing site (TCS) model for cell shape regulation in bacteria: the envelope as an integration point for the regulatory circuits of essential physiological events. Adv Microb Physiol (1994) 1.06
Resistance to beta-lactams in Mycobacterium fortuitum. Antimicrob Agents Chemother (1992) 1.06
Severity of group B streptococcal arthritis is correlated with beta-hemolysin expression. J Infect Dis (2000) 1.05
Target for bacteriostatic and bactericidal activities of beta-lactam antibiotics against Escherichia coli resides in different penicillin-binding proteins. Antimicrob Agents Chemother (1995) 1.05
Penicillins activate autolysins extracted from both Escherichia coli and Klebsiella pneumoniae envelopes. Antimicrob Agents Chemother (1977) 1.05
Critical comparison of nine different self-administered questionnaires for the evaluation of disability caused by low back pain. Eura Medicophys (2005) 1.05
Palliative treatment of upper intestinal obstruction by gynecological malignancy: the usefulness of percutaneous endoscopic gastrostomy. Gynecol Oncol (1996) 1.05
Antibiotic susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Italy, 1997-1999. Clin Infect Dis (2000) 1.04
In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics. Antimicrob Agents Chemother (1990) 1.03
Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis. J Med Virol (1997) 1.02
Role of tumor necrosis factor alpha, interleukin-1beta, and interleukin-6 in a mouse model of group B streptococcal arthritis. Infect Immun (1999) 1.02
Emergence of linezolid resistance in Enterococcus faecium not dependent on linezolid treatment. Eur J Clin Microbiol Infect Dis (2006) 1.02
Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr (2001) 1.01
Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy. Carbohydr Res (1995) 1.01
Soluble antigens from group B streptococci induce cytokine production in human blood cultures. Infect Immun (1997) 1.01
Early initiation of deoxyribonucleic acid replication and shortening of generation time associated with inhibition of lateral wall formation by mecillinam. J Bacteriol (1981) 1.00